Covid-19 Molecular Diagnostic Testing—Lessons Learned
Two FDA directors share the lessons learned during the evolution of the emergency use of diagnostics for SARS-CoV-2 during the covid-19 pandemic.
Read MorePosted by Melanie Hamilton-Basich | Sep 18, 2020 | Covid 19 |
Two FDA directors share the lessons learned during the evolution of the emergency use of diagnostics for SARS-CoV-2 during the covid-19 pandemic.
Read MorePosted by Melanie Hamilton-Basich | Sep 17, 2020 | Company News, Covid 19 |
The thresholds displayed in the standardized unit of measure for IgG may lead to a standardized interpretation of covid-19 immunity through test results.
Read MorePosted by Melanie Hamilton-Basich | Sep 16, 2020 | Covid 19 |
An aggressive approach including widespread testing helped New Mexico stem the spread of covid-19. It’s now in much better shape than surrounding states.
Read MorePosted by Melanie Hamilton-Basich | Sep 16, 2020 | Covid 19, Molecular Diagnostics |
The tables show the Limit of Detection of more than 55 authorized molecular diagnostic covid-19 tests against a standardized sample panel provided by the FDA.
Read MorePosted by Melanie Hamilton-Basich | Sep 14, 2020 | Covid 19, Rapid Assays |
The covid-19 tests are the first purchase from a multistate compact created last month to hasten development of quick-result tests.
Read More